A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Open accessThe DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index; 20 of the 36 sources its claims cite were checked for support.
Abstract
Oncogene-induced senescence (OIS) is crucial for tumour suppression. Senescent cells implement a complex pro-inflammatory response termed the senescence-associated secretory phenotype (SASP). The SASP reinforces senescence, activates immune surveillance and paradoxically also has pro-tumorigenic properties. Here, we present evidence that the SASP can also induce paracrine senescence in normal cells both in culture and in human and mouse models of OIS in vivo. Coupling quantitative proteomics with small-molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF-β family ligands, VEGF, CCL2 and CCL20. Amongst them, TGF-β ligands play a major role by regulating p15(INK4b) and p21(CIP1). Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling. The inflammasome and IL-1 signalling are activated in senescent cells and IL-1α expression can reproduce SASP activation, resulting in senescence. Our results demonstrate that the SASP can cause paracrine senescence and impact on tumour suppression and senescence in vivo.
Overview
CoChat Summary
## TL;DR
Cells undergoing oncogene-induced senescence (OIS) can transmit senescence to neighboring normal cells through secreted SASP factors, creating a stable paracrine senescence state in culture and in vivo. The paper identifies TGFβ family ligands and IL-1/inflammasome signaling as key regulators of this process.
## Key findings
- Normal IMR90 fibroblasts and HMECs became growth-arrested when co-cultured with OIS cells; the effect was transmitted through transwells and conditioned media, showing it was mediated by soluble factors rather than direct contact.
- Paracrine senescence resembled full senescence: normal cells showed increased DNA/oxidative damage, p16^INK4a^, p21^CIP1^, and SASP markers; gene-expression profiles of OIS and paracrine senescence were highly correlated and clustered together.
- Quantitative proteomics and a 78-compound screen implicated multiple SASP components in paracrine senescence, including TGFβ family ligands, VEGF, CCL2, and CCL20; blocking VEGFR2/FLT3, TGFBR1, or CCR2 partially impaired the arrest.
- The paper reports specific in vivo evidence of paracrine senescence: p21^CIP1^+/p16^INK4a^ cells were found near OIS lesions in mouse liver and skin, and in human serrated sessile adenomas the stromal p21^CIP1^/Ki-67^- signal was significantly increased near lesions (p = 0.03), with a separate comparison reporting p = 4.6 × 10^-5^ for p21^CIP1^ positive/Ki67 negative stromal cells.
## Methods
- Co-culture, transwell, conditioned-media, and cluster assays were used in human IMR90 fibroblasts and HMECs; OIS was induced with ER:RAS, MEK:ER, or related oncogenic constructs activated by 4OHT.
- Secretome analysis used SILAC-based quantitative proteomics, followed by a 78-compound receptor/pathway screen, RNAi knockdown, RT-qPCR, microarrays, GSEA, immunofluorescence/high-content analysis, and assays for BrdU, SA-β-Gal, caspase-1, and antibody arrays.
- In vivo validation used mouse OIS models including Nras-driven hepatocyte senescence, K5-Sos/Egfr^wa2/+^ skin papillomas, and Pdx1-Cre Kras^G12D^ pancreatic lesions, plus human SSA tissue IHC.
## Limitations
- The paper itself notes that “the nature of these cells and the functional implications of paracrine senescence remain open questions for future studies.”
- It also states that not all cells surrounding preneoplastic lesions undergo paracrine senescence; it proposes possible explanations such as soluble-factor gradients and cell-type susceptibility, but these are not experimentally resolved here.
- Evident from the text: many mechanistic and inhibitor results are partial (“partially rescued,” “partially prevented”), so the study does not identify a single exclusive mediator of paracrine senescence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Valid · 1 Not valid · 7 Not checked · 78 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“a transcriptional signature associated with senescence 18 was significantly upregulated during paracrine senescence (Fig 3d).”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence resembles a full senescence response
What the sources say
- Supportedcites [18] Fridman AL, Tainsky MA. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene. 2008; 27:5975-87. [PubMed: 18711403] source
The 'Genomic approaches to identify senescence/immortalization genes and pathways' section describes gene-expression profiling that identifies genes and pathways associated with senescence. In the citing sentence, the citation identifies the senescence-associated transcriptional signature; the finding that it was significantly upregulated during paracrine senescence is attributed to the citing paper’s Fig. 3d, not to this source. No page number is available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Colon SSAs are mainly driven by activating BRAF mutations that trigger OIS 31,34,35 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence is observed in mouse and human models of OIS in vivo
What the sources say
- Partly supportedcites [31] Carragher LA, et al. V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Mol Med. 2010; 2:458-71. [PubMed: 20941790] sourceExperimental — accuracy not yet measured
The Discussion reports V600E BRAF mutations in approximately 70% of right-sided serrated hyperplastic polyps and serrated adenomas, supporting a major role for BRAF in the serrated pathway. The Results show that V600E Braf induces senescence in mouse small-intestinal crypts, but do not establish that BRAF mutations trigger OIS in human colon sessile serrated adenomas. (LLM, conf=0.87)
- Partly supportedcites [34] Kriegl L, et al. Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/ adenomas indicates a senescence barrier in the serrated route to colon cancer. Modern Pathology. 2011; 24:1015-22. [PubMed: 21423154] sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says that initiating BRAF mutations might drive oncogene-induced senescence in human serrated polyps, and concludes that the data provide evidence for senescence in the BRAF-mutated serrated route. It does not establish that colon sessile serrated adenomas are mainly driven by BRAF mutations: the study selected BRAF-mutated lesions for its final analysis, and its proposed causal link is hedged. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [35] Bennecke M, et al. Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell. 2010; 18:135-46. [PubMed: 20708155] source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A signature derived from IMR90 cells undergoing paracrine senescence is found enriched in mouse PANIN 44 and human serrated sessile adenomas (SSA) 36 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > REFERENCES
What the sources say
- Partly supportedcites [44] Ling J, et al. KrasG12D-induced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell. 2012; 21:105-20. [PubMed: 22264792] sourceExperimental — accuracy not yet measured
The Results section, “Inhibition of Key Proinflammatory Cytokines,” reports gene-expression profiles from mouse PanIN, so this paper provides the mouse PanIN data cited as reference 44. It does not report testing or finding enrichment of an IMR90 paracrine-senescence signature in those profiles. The SSA finding is attached to a different citation (36), not this source. (LLM, conf=0.79)
- Not checked — no full text of the sourcecites [36] Caruso M, et al. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Virchows Archiv. 2009; 454:291-302. [PubMed: 19172291] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
- Also stated in: § Abstract · plain
“Coupling quantitative proteomics with small molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling.”
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
54 more claims
Create a free account to see all 101 claims and every source verdict.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 21
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The senescent cell fate can be triggered by a number of stressors including DNA damage, cancerous mutations or oncogene activation, mitochondrial dysfunction, reactive metabolites, hyperoxia or hypoxia, proteotoxic stress, extracellular signals, infections, mechanical or shear stresses that deform cells, resistance exercise and factors secreted by other senescent cells18,38–47.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The inflammasome, a multiprotein complex comprising caspase 1 and key regulators of the defence mechanisms against pathogens117, and Toll-like receptors, which regulate the inflammasome, have been reported to promote maturation and secretion of SASP factors during OIS73,118.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, specific SASP components, either soluble or in extracellular vesicles186, can induce senescence in a paracrine manner — which includes DDR activation73,83.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upstream signals triggering SASP activation are multiple and differ depending on the senescence inducer but include DNA damage, cytoplasmic chromatin fragments (CCFs) that trigger a type 1 interferon response, and damage-associated molecular patterns (DAMPs) that activate the inflammasome (Acosta et al., 2013; Davalos et al., 2013; Li and Chen, 2018).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher secretion of SASP factors is also associated with an enhanced immune response, leading to inflammation which may promote tumorigenesis (Acosta et al., 2013).”
From Single senescent cell sequencing reveals heterogeneity in senescent cells induced by telomere erosion (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measured
47 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationPreinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Cited by
Items 1,601–1,700 of 2,275
Ho, C. Z., Deng, L., Picone, R., Abderazzaq, F. O., Flanagan, N., Chua, D. Z., Low, B. C., & Wu, S. K. (2025) · Molecular Biology of the Cell · doi:10.1091/mbc.e24-10-0445 · Cited by 7
The impact of cellular senescence on aging skeletal muscle
Kamal, M. J., Bevington, R. T., Johnson, A., & Parise, G. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1719279 · Cited by 8
“Importantly, senescent cells are also capable of metabolically reprogramming adjacent, non-senescent cells through the actions of the SASP (discussed further below) (Acosta et al., 2013).”
Cellular senescence in age-related cardiovascular disease: past and future
Wu, X., Zhou, Q. S., Huang, Y., Jiang, W., Zhou, J., Qian, K., Pan, Y. P., Wu, Z., Zhang, J., Aimaiti, M., et al. (2026) · Frontiers in Aging · doi:10.3389/fragi.2025.1721744 · Cited by 10
Evaluating senescence-targeted approaches in Alzheimer’s Disease: What we know and what lies ahead
Doshi, P. P., Desale, S. H., Khutale, A. A., Sabarathinam, S., & Suresh, S. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103029 · Cited by 8
Sayed, S. E., Saiyed, D., Macri, V. I., Asamoah‐Mensah, A., Segars, J. H., & Islam, M. S. (2026) · Nutrients · doi:10.3390/nu18030393 · Cited by 9
“Senescent cells develop a senescence-associated secretory phenotype (SASP), which involves secretion of proinflammatory cytokines, chemokines, and proteases [74].”
Biomarkers of ageing in the study of occupational harm impacts (literature review)
Karimov, D. D., Kudoyarov, E. R., Mukhammadiyeva, G. F., Зиатдинова, М. М., Baygildin, S. S., & Yakupova, T. G. (2021) · Hygiene and Sanitation · doi:10.47470/0016-9900-2021-100-11-1328-1332 · Cited by 9
Chandrasegaran, S., Scanlan, R.-L., Clark, P. A., Pease, L. I., Wordsworth, J., & Shanley, D. P. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_16 · Cited by 5
Targeting cellular senescence as a therapeutic vulnerability in gastric cancer
Geng, H., Huang, C., Xu, L., Zhou, Y., Dong, Z., Zhong, Y., Li, Q., Yang, C. G., Huang, S., Liao, W., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122631 · Cited by 8
Exploring the Complexity and Promise of Tumor Immunotherapy in Drug Development
Feng, Y., He, C., Liu, C., Shao, B., Wang, D., & Wu, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126444 · Cited by 7
“Crucially, SASP can propagate senescence, as it contains prohormonal factors released in extracellular vesicles [108], which in turn further propagate SASP [109].”
BackgroundRegulatory Effects of Senescent Mesenchymal Stem Cells: Endotheliocyte Reaction
Ratushnyy, A. Y., Ездакова, М. И., Константиновна, М. Д., Tyrina, E. A., & Buravkova, L. B. (2024) · Cells · doi:10.3390/cells13161345 · Cited by 5
“Nevertheless, it has been demonstrated that a “chronic” SASP is capable of inducing senescence in adjacent young cells, thereby contributing to tissue dysfunction [75] and, paradoxically, tumorigenesis [41].”
BackgroundImmune therapeutic strategies for the senescent tumor microenvironment
Yasuda, T., & Wang, Y. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02865-7 · Cited by 10
Misceo, D., Mocciaro, G., D’Amore, S., & Vacca, M. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00871-3 · Cited by 7
“Senescence promotes SLD progression and a precancerous niche through: (1) the production of senescence-associated secretory phenotype (SASP) that will induce a cascade effect amplifying senescence [170] and inflammation [171]; and (2) the impairment of systemic and hepatic metabolism [172–174].”
Metabolism and metabolomics in senescence, aging, and age-related diseases: a multiscale perspective
Wang, Z., Zhu, H., & Xiong, W. (2025) · Frontiers of Medicine · doi:10.1007/s11684-024-1116-0 · Cited by 7
Borges, G. Á., Diaz‐delCastillo, M., Guilatco, A. J., El-Masri, B. M., Mustapha, F., Gundesen, M. T., Hinge, M., Lund, T., Abdallah, N. H., Baughn, L. B., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02572-z · Cited by 6
Qin, X., Lü, F., Wan, J., Teng, X., Jin, S., Xiao, L., Xue, H., Guo, Q., Tian, D., & Wu, Y. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.04.005 · Cited by 8
Giroud, J., Delvaux, P., Carlier, L., de Schutter, C., Martin, N., Rouget, R., Bolouki, A., Glas, V. D., Bouriez, I., Bourdoux, F., et al. (2025) · Aging Cell · doi:10.1111/acel.70024 · Cited by 7
Senolytics rejuvenate the reparative activity of human cardiomyocytes and endothelial cells
Sunderland, P., Al-Shammari, L. A. C., Ambrose, E., Torella, D., & Ellison, G. M. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.07 · Cited by 8
Staphylococcus aureus phagocytosis is affected by senescence
Robledo, E., Rodriguez, P. G. B., Vega, I. A., Colombo, M. I., & Aguilera, M. O. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1198241 · Cited by 5
“But if the signal persists, non-damaged cells may undergo senescence (Acosta et al., 2013).”
BackgroundSATB1, senescence and senescence‐related diseases
Qi, W., Bai, J., Wang, R., Zeng, X., & Zhang, L. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31327 · Cited by 6
Weiss, A. M., López, M. A., Rosenberger, M. G., Kim, J. Y., Shen, J., Chen, Q., Ung, T. W.-M., Ibeh, U., Knight, H. R., Rutledge, N. S., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00516 · Cited by 4
The Aging Immune System: A Critical Attack on Ischemic Stroke
Xu, W., Guo, Y., Zhao, L., Fu, R., Qin, X., Zhang, Y., Cheng, X., & Xu, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04464-2 · Cited by 6
“Interestingly, some cytokines secreted by inflammasomes, such as TGF-β and IL-1α, act as mediators that promote the paracrine propagation of SASP and worsen senescence progression [19].”
TPR is required for cytoplasmic chromatin fragment formation during senescence
Bartlett, B. M., Kumar, Y., Boyle, S., Chowdhury, T., Quintanilla, A., Boumendil, C., Acosta, J. C., & Bickmore, W. A. (2024) · eLife · doi:10.7554/elife.101702 · Cited by 7
Self-citationXiao, L., Gao, W., Wu, J., Erezuma, I., Dolatshahi‐Pirouz, A., Silva‐Correia, J., Zhou, Y., Sun, A. R., Prasadam, I., Crawford, R., et al. (2025) · Regenerative medicine and dentistry. · doi:10.53941/rmd.2025.100001 · Cited by 9
Wu, M., Wu, B., Huang, X., Wang, Z., Zhu, M., Zhu, Y., Yu, L., & Liu, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06216-9 · Cited by 10
“Even though we demonstrated that SASP factors secreted by FEN1 knockdown cells could inhibit tumor cell proliferation in vitro, but, the types and functions of SASP factors secreted by early and late senescent tumor cells are different [33].”
InfluentialMultidrug resistance protein 3 loss promotes tumor formation by inducing senescence escape
Wiel, C., Gras, B., Vindrieux, D., Warnier, M., Gitenay, D., Calvé, B. L., Ferrand, M., Augert, A., & Bernard, D. (2015) · Oncogene · doi:10.1038/onc.2015.218 · Cited by 7
Roles of eIF5A in the immunosurveillance of cellular senescence
Jiang, X., Loayza‐Puch, F., #x2019, & Loayza-Puch, F. (2022) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2022.0408 · Cited by 6
Dietary restriction in senolysis and prevention and treatment of disease
Aminzadeh-Gohari, S., Kofler, B., & Herzog, C. M. S. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2153355 · Cited by 6
“…growth factors, and proteases into the tissue microenvironment, have been shown to elicit bystander senescence and cause stem cell exhaustion (Acosta et al. 2013; Hubackova et al. 2012; Chang et al. 2016; Molofsky et al. 2006), contribute to expansion of preneoplastic cells (Krtolica et al.…”
Is aging a “Retro”spective event?
Dasgupta, N., & Adams, P. D. (2023) · Cell · doi:10.1016/j.cell.2022.12.040 · Cited by 6
Premature senescence of the liver in Alagille patients
Jannone, G., de Magnée, C., Tambucci, R., Evraerts, J., Ravau, J., Najimi, M., & Sokal, E. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285019 · Cited by 6
“We indeed observed that other SASP components promoting the paracrine transmission of senescence such as CCL2 and CCL20 were upregulated in ALGS livers RNA sequencing dataset, corroborating the fact that other senescence pathways might compensate the abnormal Notch signaling [11, 19, 20].”
BackgroundHerath, D., Even, B., Oranger, M., Foresti, R., Papy-García, D., Boyer, L., Boczkowski, J., & Dagouassat, M. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.05.025 · Cited by 5
Hautalterung – zelluläre Seneszenz: Wohin geht die Reise?
Scharffetter‐Kochanek, K., Wang, Y., Makrantonaki, E., Crișan, D., Wlaschek, M., Geiger, H., & Maity, P. (2023) · Die Dermatologie · doi:10.1007/s00105-023-05201-x · Cited by 5
Senescence Associated Heterochromatic Foci: SAHF
Chandra, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-38882-3_9 · Cited by 8
The Enigmatic Vascular NOX: From Artifact to Double Agent of Change
Pagano, P. J., & Cifuentes-Pagano, E. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.13897 · Cited by 7
Franceschi, C., Capri, M., Garagnani, P., Ostan, R., Santoro, A., Monti, D., & Salvioli, S. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_45 · Cited by 8
Cellular senescence and liver cancer: a gut microbial connection
Yoshimoto, S., Loo, T. M., & Hara, E. (2015) · Inflammation and Regeneration · doi:10.2492/inflammregen.35.106 · Cited by 5
Varela-Eirín, M., Varela-Vázquez, A., Paı́no, C. L., Casado‐Díaz, A., Continente, A. J. C., Mato‐Abad, V., Fonseca, E., Kandouz, M., Blanco, A., Caeiro, J. R., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/686535 · Cited by 5
Evans, S. A., Teo, Y. V., Clark, K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.16.448710 · Cited by 5
“SASP leads to inflammation disrupting the tissue microenvironment, reinforces the senescent phenotype by contributing to the cell cycle arrest, and can induce paracrine senescence in normal cells [8, 9].”
Conserved transcriptomic signatures and protein markers in cellular senescence modelsPreprint
Skea, D., Fotis, C., Tsolakos, N., Pliaka, V., Verrou, K., & Alexopoulos, L. G. (2023) · Research Square · doi:10.21203/rs.3.rs-3110821/v1 · Cited by 4
SOX2 drives fetal reprogramming and reversible dormancy in colorectal cancerPreprint
Baulies, A., Moncho-Amor, V., Garcia, D. D., Kucharska, A., Chakravarty, P., Moreno‐Valladares, M., Cruces‐Salguero, S., Hubl, F., Hutton, C., Kim, H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.11.612412 · Cited by 7
Kelsey, M. M. G., Dalgarno, A., Evans, S. A., Nuñez, T. A., Rocha, A. V., Clark, K., Sedivy, J. M., & Neretti, N. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.11.659151 · Cited by 7
Xia, Z., Liu, W., Zeng, F., Kang, S., Li, J., Xu, W., Tang, P., Zheng, X., Li, D., Yang, X., et al. (2025) · Cosmetics · doi:10.3390/cosmetics12020085 · Cited by 4
“In skin-related diseases, SASPs not only promote the occurrence of chronic inflammation but also induce normal cells to enter the aging process, forming a vicious cycle of inflammation and aging [11,12].”
de Mendonça, L. B., Lenz, G., & Filippi‐Chiela, E. C. (2025) · Biochemical Society Transactions · doi:10.1042/bst20253054 · Cited by 5
“Concerning the dominant biological impact, for instance, the SASP can be pro-fibrotic [36,37], pro-angiogenic [38,39], pro-inflammatory [40], or pro-senescent [41–43].”
Ding, L., Wang, X., Liu, Q., Zhang, Y., Wu, X., Xiao, B., Liu, D., Chen, L., Zeng, H., Zhao, B., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01442 · Cited by 4
Li, W., Han, Y., Wang, P., & Qiao, S. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70803 · Cited by 7
“31 The SASP, including HMGB1, could also promote the expression of inflammatory The entwined vicious cycle between brain cellular senescence and AD pathology.”
Targeting telomere dynamics with plant-derived compounds: Molecular strategies against aging
Akter, R., Bishakha, A. C., Rajib, R., Raj, A., Roja, M. S., & Noor, F. (2025) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2025.100238 · Cited by 7
“This activity propagates the senescence phenotype and exacerbates age-related tissue decline (Acosta et al., 2013).”
Antonangeli, F., Arcuri, E., & Santoni, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1694567 · Cited by 4
Hallmarks of the Aging Skin Microenvironment: Components and Mechanisms
He, R., Sun, M., Liu, T., Geng, L., Xing, C., Xu, P., Peng, Y., & Fang, Y. (2025) · Journal of Cellular Physiology · doi:10.1002/jcp.70111 · Cited by 8
“The secretory profile exhibits a dual role: promoting tissue repair through paracrine activation of immune ‐ mediated senescent cell clearance or wound healing while concurrently driving inflammaging (Acosta et al. 2013; Kang et al. 2011).”
Zhang, P., Zhang, H., Zemin, L., Pang, S., Hu, J., Wang, Y., Su, Z., Wang, J., Xiao, Y., Wang, K., et al. (2026) · Advanced Functional Materials · doi:10.1002/adfm.202529224 · Cited by 5
“Depending on the type of senescent cells and the phase of the regeneration process, senescent cells can have either beneficial or adverse effects [8, 12, 13 ].”
The m⁶A epitranscriptome: A regulatory nexus linking cellular senescence and oncogenesis
Xu, Y., Zhou, X., Su, X., Xie, W., Huang, Z., Yu, S., Tan, J., He, J., & Zhang, J. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103032 · Cited by 6
Chronic Kidney Disease and Cellular Senescence
Morevati, M., Tavenier, J., Scheibye‐Knudsen, M., Houlind, M. B., Hedayati, A., & Hornum, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073205 · Cited by 6
“The first mechanism, known as paracrine senescence, involves releasing SASP factors that propagate senescence both locally and systemically in the extracellular fluid and via the bloodstream [58].”
Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP)
Malaquin, N., & Rodier, F. (2022) · Methods in cell biology · doi:10.1016/bs.mcb.2022.10.005 · Cited by 9
Kraa, J. J., Agyapong, A., Kwateng, K. O., & Owusu, J. (2025) · Strategy and Leadership · doi:10.1108/sl-01-2025-0001 · Cited by 8
Future Perspectives in Senescence-Based Therapies for Head and Neck Cancer
Palomares, B. H., Martins, M. D., Martins, M. A. T., SQUARIZE, C. H., & CASTILHO, R. M. (2025) · Cancers · doi:10.3390/cancers17121965 · Cited by 4
“Hence, senescent cells secrete multiple SASP factors, including TGF-β family ligands, CCL2, CCL20, and VEGF, which can damage the DNA of neighboring cells and induce senescence in adjacent cells by increasing the expression of p16, p21, and IL-8 [53,54].”
Tang, X., Xu, Y., Ou, N., Tang, Y., & Chen, H. (2025) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qeaf043 · Cited by 4
Bioelectric characterization of senescing human keratinocytes
Sediqi, H., & Levin, M. G. (2025) · iScience · doi:10.1016/j.isci.2025.113275 · Cited by 7
Hodge, J., Medina-Lopez, A., Neal, C. A., Decker, H. E., Robinson, J. L., & Mellott, A. J. (2025) · Regenerative Medicine · doi:10.1080/17460751.2025.2572177 · Cited by 5
“Previous studies have shown that senescent cell populations can impair the regenerative functionality of surrounding cell populations via SASP [96,97].”
Stem Cell Senescence as the Memory of Past Injuries
Gianfranceschi, G., Gri, G., Cesselli, D., & Beltrami, A. P. (2015) · Current Pathobiology Reports · doi:10.1007/s40139-015-0071-5 · Cited by 5
Age-related functional decline of human B cells
Fujiki, T., Matsumoto, S., Kishihara, K., & Katakura, Y. (2022) · Cytotechnology · doi:10.1007/s10616-021-00513-z · Cited by 5
Extracellular Vesicles and Cellular Ageing
Romero-García, N., Mas‐Bargues, C., Huete-Acevedo, J., & Borrás, C. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_11 · Cited by 6
Receptor-Independent Therapies for Forensic Detainees with Schizophrenia–Dementia Comorbidity
Sfera, A., Andronescu, L., Britt, W. G., Himsl, K., Klein, C. A., Rahman, L., & Kozlakidis, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115797 · Cited by 3
“This may be significant as anti-ferroptotic agents, as well as iron chelators, may comprise viable treatment options for bvFTD and other dementias [93–95].”
BackgroundBorowik, A., Lawrence, M. M., Peelor, F. F., Piekarz, K. M., Crosswhite, A., Richardson, A. G., Miller, B. F., Remmen, H. V., & Brown, J. L. (2024) · GeroScience · doi:10.1007/s11357-024-01070-x · Cited by 4
“Cellular senescence is linked to age-related disease and dysfunction [8–10] through the production of the senescence-associated secretory phenotype (SASP) [11, 12].”
Shen, J., Hu, L., Huang, X., Mao, J., Wu, Y., Xie, Z., & Lan, Y. (2024) · Bone · doi:10.1016/j.bone.2024.117076 · Cited by 8
Cellular senescence: mechanisms and clinical implications
Михайловна, М. А., Pashenkov, M. V., & Pinegin, B. V. (2024) · Immunologiya · doi:10.33029/1816-2134-2024-45-2-221-234 · Cited by 10
Murthy, S., Seabold, D., Gautam, L. K., Caceres, A. M., Sease, R., Calvert, B. A., Busch, S. M., Neely, A., Marconett, C. N., & Ryan, A. L. (2025) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00293.2024 · Cited by 6
Natural Product-Derived Senotherapeutics: Extraction and Biological Evaluation Techniques
Pratsinis, H., Mavrogonatou, E., Zervou, S., Triantis, T. M., Hiskia, A. E., & Kletsas, D. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4426-3_19 · Cited by 4
Stücker, S., Koßlowksi, F., Buchholz, A., Schwab, A., Halm‐Pozniak, A., Lohmann, C. H., & Bertrand, J. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1535530 · Cited by 5
Zhang, Y., Qiu, J., Chen, Y., Chen, Y., Liu, X., Zhang, H., Li, H., Li, K., Ye, H., Wu, Y., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101729 · Cited by 4
“Studies have demonstrated that the deletion of the NLRP3 inflammasome can prevent various aging-driven phenotypes [10].”
Analysis of the senescence secretome during zebrafish retina regeneration
Konar, G. J., Vallone, K. T., Nguyen, T. D., & Patton, J. G. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1569422 · Cited by 5
Telomerase Depletion Accelerates Ageing of the Zebrafish Brain
Martins, R. R., Besse, S., Ellis, P. S., Sevil, R., Hartopp, N., Purse, C., Everett‐Brown, G., Evans, O., Mughal, N., Wahib, M. H. F., et al. (2025) · Aging Cell · doi:10.1111/acel.70280 · Cited by 5
Nikolov, S. G., Santos, G., Olaf Wolkenhauer, A., & Vera, J. (2017) · Bulletin of Mathematical Biology · doi:10.1007/s11538-017-0378-y · Cited by 4
Fontanilla-Ramirez, P., Willaume, S., Thezé, B., Moussa, A., Pennarun, G., & Bertrand, P. (2020) · médecine/sciences · doi:10.1051/medsci/2020241 · Cited by 6
Molecular mechanisms of cellular senescence
Nehme, J., Varela-Eirín, M., & Demaria, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823318-4.00034-2 · Cited by 4
Antioxidant and Anticancer Functions of Protein Acyltransferase DHHC3
Sharma, C., & Hemler, M. E. (2022) · Antioxidants · doi:10.3390/antiox11050960 · Cited by 5
Therapeutic Potential of a Senolytic Approach in a Murine Model of Chronic GVHD
Raman, D., Chêne, C., Nicco, C., Jeljeli, M. M., Eu, J. Q., Clement, M., Batteux, F., & Pervaiz, S. (2023) · Biology · doi:10.3390/biology12050647 · Cited by 6
“Intrigued by the effect of DQ on serum levels of cytokines such as IL-4, IL-6 and IL8Rα, which have been associated with SASP, we next queried if the beneficial effect of DQ was a function of its ability to target a pool of senescent cells induced upon allografting.”
BackgroundInfluentialYin, F., Zhao, W., Ding, C., Hou, C., Wang, S., Sun, C., Zhao, Z., Zhang, Z., Ren, F., Liu, Y., et al. (2024) · Journal of Cancer · doi:10.7150/jca.96107 · Cited by 4
“SASP can also play the opposite role by promoting senescent cells through autocrine or paracrine peri cells to undergo senescence, thereby suppressing tumor cells [8,9].”
BackgroundMacrophages in age-related macular degeneration: a narrative review
Khademi, S., Yu, Z., Zhou, T., Song, B., & Xu, Z. (2024) · Aging advances. · doi:10.4103/agingadv.agingadv-d-24-00007 · Cited by 5
Senescent cells and the dynamics of agingPreprint
Karin, O., Agrawal, A., Porat, Z., Krizhanovsky, V., & Alon, U. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/470500 · Cited by 4
“…Fagagna et al., 2003; Karlseder et al., 2002; Shay and Wright, 2004) (ii) SnC can catalyze their own production by paracrine and bystander effects (Acosta et al., 2013; Nelson et al., 2012, 2018), (iii) SnC removal rate can decrease with age due to age-related decline in immune surveillance…”
BackgroundGrzeczka, A., Graczyk, S., & Kordowitzki, P. (2025) · GeroScience · doi:10.1007/s11357-025-01520-0 · Cited by 7
Unraveling senescence in cancer: mechanistic complexities and therapeutic opportunities
Tiwari, P., Shukla, S. K., & Verma, S. R. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10630-z · Cited by 5
Acetylation in Cardiac Aging: Molecular Mechanism and Therapeutic Approaches
Hase, A. D., & Banerjee, S. (2025) · Results and problems in cell differentiation · doi:10.1007/978-3-031-91459-1_9 · Cited by 4
The Role of Telomeres in Senescence, Aging and Disease: Fiction and Reality
Saretzki, G. C. (2025) · OBM Geriatrics · doi:10.21926/obm.geriatr.2503324 · Cited by 4
Senescent fibroblasts modulate the radiation response of neighboring epithelial cells
Buchholzki, M., Stasch, L. M., Budeus, B., Ketheeswaranathan, V., Sevindik, Z. F., Jendrossek, V., & Klein, D. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02796-z · Cited by 6
Tang, X., Hu, J., Fan, X., Su, H., Li, M., Zhang, L., & Ma, D. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00541-9 · Cited by 4
“Paracrine senescence, mediated by SASP factors such as TGF-β ligands, VEGF, CCL2, and CCL20, describes how senescent cells propagate senescence to neighboring healthy cells via secreted factors [67].”
Park, S., Baek, S., Shin, H.-J., Hwang, J. Y., Yoo, D. S., Seo, D. B., & Bae, S. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17121560 · Cited by 5
“These cells promote SASP secretion, amplify inflammatory signaling, and propagate paracrine senescence, thereby accelerating cutaneous aging [3,8,9].”
Steegen, L., & Grootaert, M. O. J. (2026) · Cells · doi:10.3390/cells15020114 · Cited by 4
“In parallel, paracrine signaling allows senescent cells to induce inflammation and DNA damage in neighboring healthy cells, known as ‘paracrine’ or ‘bystander’ senescence [24,29].”
DEL‐1 is an Endogenous Senolytic Protein that Inhibits Senescence‐Associated Bone Loss
Lim, J., Sirisereephap, K., Wang, H., Trimaglio, G., Chung, K., Korostoff, J. M., Kajikawa, T., Li, X., Surboyo, M. D. C., Maekawa, T., et al. (2026) · Advanced Science · doi:10.1002/advs.202509263 · Cited by 5
Yang, W.-X., Pang, Y., Liao, M.-C., Peng, J., Leal, D. N., Yamashita, M., Miyata, K. N., Filep, J. G., Ingelfinger, J. R., Zhang, S., et al. (2026) · Clinical Science · doi:10.1042/cs20258557 · Cited by 5
Characterizing the SASP ‐Dependent Paracrine Spreading of Senescence Between Human Brain Cell Types
Russo, T., & Rießland, M. (2026) · Aging Cell · doi:10.1111/acel.70673 · Cited by 4
Ju, N., Zhao, L., Yin, S., Yang, X., Zhou, J., Gao, J., & Qi, F. (2026) · International Journal of Cancer · doi:10.1002/ijc.70442 · Cited by 6
“105 However, depending on stage and context, senescence signaling may also be pro-tumorigenic, promoting EMT 106 and immunosuppression, 107 underscoring its stage-and context-dependent roles in tumor progression and antitumor immunity.”
Natural Products as Anti-Senescence-Associated Secretory Phenotype (SASP) Agents
Yang, L., Liu, Y., Li, Y., Fu, P., & Ma, L. (2026) · Current Medicinal Chemistry · doi:10.2174/0109298673399133251206205537 · Cited by 5
Choi, M., Lee, D., Yang, W.-H., & Cha, J. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08688-z · Cited by 4
“…inhibitors [e.g., ruxolitinib] and mTOR inhibitors [e.g., rapamycin] both attenuate the expression of immunosuppressive SASP factors [IL-6, IL-8, CXCL1] [39, 117, 128], limiting chronic in fl ammation [129], secondary senescence propagation [130], T-cell exhaustion [131], and myeloid skewing [132].”
Tan, S., Nepovimová, E., Valko, M., Jomová, K., Wu, Q., & Kuča, K. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02855-7 · Cited by 13
“This phenomenon, termed paracrine senescence, expands the traditional concept of cellular senescence beyond cell-autonomous effects to encompass its systemic impact on tissue homeostasis and organ-ismal aging [67–69].”
Senescence Programs Shape the Chronic Wound Microenvironment
Shvedova, M., Cho, M., Eyckmans, J., & Roh, D. S. (2026) · Advances in Wound Care · doi:10.1177/21621918261441046 · Cited by 3
Qiao, Y., Zhao, J., Liu, M., Liu, J., Qiao, Z., Xu, R., Ning, X., Sun, S., & Chen, X. (2026) · Biomolecules · doi:10.3390/biom16040611 · Cited by 3
“Although SASP is initially beneficial for tissue repair, normal tissue development, and the recruitment of immune cells, its persistent presence might give rise to enduring inflammatory reactions, induce more severe cellular senescence, and ultimately lead to organ dysfunction [12,27,37,38].”
Evolution and development of innate immune memory
Divangahi, M., & Kaufmann, E. (2026) · Science Immunology · doi:10.1126/sciimmunol.aeb7976 · Cited by 7
Jin, Y., Yaegashi, D., Shi, L., Ishida, M., Sakai, C., Yokokawa, T., Abe, Y., Sakai, A., Yamaki, T., Kunii, H., et al. (2022) · International Heart Journal · doi:10.1536/ihj.22-037 · Cited by 5
Inflammasome Coordinates Senescent Chronic Wound Induced by Thalassophryne nattereri Venom
Lima, C., Andrade‐Barros, A. I., Carvalho, F. F., Falcão, M. A. P., & Lopes‐Ferreira, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098453 · Cited by 3
“As well as senescence-associated macrophages, senescent fibroblasts also show increased expression of NLRP3 and caspase-1 [39], and that caspase-11 non-canonical inflammasome acts in immune-mediated senescent cells in vivo [21,40].”
BackgroundVoskamp, C., Koevoet, W. J. L. M., van Osch, G. J. V. M., & Narcisi, R. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1241338 · Cited by 5
A precise dual-drug codelivery nanosystem for treating kidney failure by eliminating senescent cells
Jin, S., Li, W., Huang, Q., Zeng, X., & Zhang, X. (2024) · Science China Materials · doi:10.1007/s40843-024-2864-5 · Cited by 4
Verlinden, S. F. F. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1452453 · Cited by 5
Metadata
- Authors
- Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., Pascual, G., Morris, K. J., Khan, S., Jin, H., Dharmalingam, G., Snijders, A. P., Carroll, T., Capper, D., Pritchard, C., Inman, G. J., Longerich, T., Sansom, O. J., Benitah, S. A., Zender, L., & Gil, J.
- Affiliations
- Imperial College London (GB)
- Centre for Genomic Regulation (ES)
- Cancer Research UK Scotland Institute (GB)
- University of Tübingen (DE)
- German Cancer Research Center (DE)
- University of Leicester (GB)
- University of Dundee (GB)
- Corresponding author
- Gil, Jesús
- ORCID
- Acosta, Juan Carlos
- Banito, Ana
- Janich, Peggy
- Morton, Jennifer P.
- Athineos, Dimitris
- Lasitschka, Felix
- Andrulis, Mindaugas
- Pascual, Gloria
- Khan, Sadaf
- Jin, Hong
- Snijders, Ambrosius P.
- Carroll, Thomas
- Capper, David
- Pritchard, Catrin
- Inman, Gareth J.
- Longerich, Thomas
- Sansom, Owen J.
- Benitah, Salvador Aznar
- Zender, Lars
- Gil, Jesús
- Venue
- Nature Cell Biology
- Published
- 2013-06-16
- Volume
- 15
- Issue
- 8
- Pages
- 978-990
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC3732483
- OpenAlex
- W2140930678
- Semantic Scholar
- 59786bed7ce43f9317328cd82838f14d911e5dd4
- Cited by
- 2,278
- References
- 54
- Citations by year
- 2026: 247 · 2025: 225 · 2024: 232 · 2023: 240 · 2022: 264 · 2021: 250 · 2020: 202 · 2019: 154 · 2018: 119 · 2017: 107 · 2016: 89 · 2015: 79 · 2014: 56 · 2013: 13
- FWCI
- 54.88
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-04-28)
- Open access
- green
- europepmc.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- NERC Open Research Archive (Natural Environment Research Council) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (acceptedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Cancer Research UK (A7769, 13083, 11650, 12481)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- oncogene-induced senescence, senescence-associated secretory phenotype, paracrine senescence, inflammasome, IL-1 signaling, TGF-beta ligands, vascular endothelial growth factor, MCP-1, CCL20, CDKN2B, p21, tumor suppression, senescence-associated secretome
- MeSH terms
- Animals, Colonic Neoplasms, Humans, Immunohistochemistry, Interleukin-1, Protein Binding, Signal Transduction, Gene Expression Regulation, Neoplastic, Cellular Senescence, Paracrine Communication, Models, Animal, Cell Line, Tumor, Mice, Transforming Growth Factor beta1, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.